4//SEC Filing
Regan Daniel Paul 4
Accession 0001114220-18-000075
CIK 0001114220other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 5:59 PM ET
Size
7.0 KB
Accession
0001114220-18-000075
Insider Transaction Report
Form 4
Regan Daniel Paul
Director
Transactions
- Award
Common Stock
2018-06-30+10,000→ 60,000 total - Award
Stock Options (right to buy)
2018-06-30+30,000→ 30,000 totalExercise: $3.76From: 2019-06-30Exp: 2028-06-30→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 30, 2019, June 30, 2020 and June 30, 2021.
- [F2]Includes 19,999 shares of restricted stock.
- [F3]The 30,000 stock options vest as to one-third on each of June 30, 2019, June 30, 2020 and June 30, 2021.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeother
Related Parties
1- filerCIK 0001571320
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 5:59 PM ET
- Size
- 7.0 KB